Syndax
Peter Ordentlich

Peter Ordentlich

Chief Scientific Officer and Founder at Syndax

Peter Ordentlich has a Ph.D. in Immunology from the University of Pennsylvania and has a strong background in scientific research. Peter has held various scientific positions at Salk Institute, X-Ceptor Therapeutics, and currently serves as the Chief Scientific Officer and Vice President of Translational Medicine at Syndax Pharmaceuticals.

Links

Previous companies

Org chart

Manager

Michael A. Metzger

CEO

Peers

Anjali Ganguli

Chief Business Officer

Steve Sabus

Chief Commercial Officer

Kate Madigan

Chief Medical Officer

Teams

CEO and Executive Team

2 members

Founding Team

1 members

Leadership Team

2 members

Timeline

Chief Scientific Officer and Founder
Current role

View in org chart